EOM Pharmaceuticals Holdings, Inc. (IMUC)
EOM Pharmaceuticals Holdings, Inc. operates in the Biotechnology industry of the Healthcare sector, headquartered in Montvale, NJ, US. The stock last traded at $0.24, up 8.18% on the session, giving a market capitalisation of $30.1M. On trailing twelve-month figures it carries a trailing P/E of -15.66, a net margin of 0.0%. Its beta of 0.17 implies it has historically moved less than the broad market.
EOM Pharmaceuticals Holdings, Inc. is a clinical-stage biopharmaceutical firm dedicated to developing innovative medications. These treatments hold the potential to revolutionize existing therapeutic approaches. Among its key drug candidates currently undergoing development are EOM613 and EOM147. Established on March 20, 1987, the company maintains its corporate headquarters in Montvale, New Jersey.
EOM Pharmaceuticals Holdings, Inc. is most often compared with the following Healthcare names: